COVID-19 in a MS patient treated with ocrelizumab: does immunosuppression have a protective role?

BACKGROUND: Coronavirus disease 19 (COVID-19) is a novel disease entity that is spreading throughout the world. It has been speculated that patients with comorbidities and elderly patients could be at high risk for respiratory insufficiency and death. Immunosuppression could expose infected patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Novi, Giovanni, Mikulska, Malgorzata, Briano, Federica, Toscanini, Federica, Tazza, Francesco, Uccelli, Antonio, Inglese, Matilde
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156942/
https://www.ncbi.nlm.nih.gov/pubmed/32315980
http://dx.doi.org/10.1016/j.msard.2020.102120

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7156942/
https://www.ncbi.nlm.nih.gov/pubmed/32315980
http://dx.doi.org/10.1016/j.msard.2020.102120

Ejemplares similares